SELLAS Life Sciences Group (SLS) Consolidated Net Income: 2010-2023
Historic Consolidated Net Income for SELLAS Life Sciences Group (SLS) over the last 9 years, with Dec 2023 value amounting to -$37.9 million.
- SELLAS Life Sciences Group's Consolidated Net Income rose 13.43% to -$8.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$37.9 million, marking a year-over-year increase of 9.73%. This contributed to the annual value of -$37.9 million for FY2023, which is 8.31% up from last year.
- Per SELLAS Life Sciences Group's latest filing, its Consolidated Net Income stood at -$37.9 million for FY2023, which was up 8.31% from -$41.3 million recorded in FY2022.
- In the past 5 years, SELLAS Life Sciences Group's Consolidated Net Income registered a high of -$16.8 million during FY2020, and its lowest value of -$41.3 million during FY2022.
- Over the past 3 years, SELLAS Life Sciences Group's median Consolidated Net Income value was -$37.9 million (recorded in 2023), while the average stood at -$33.3 million.
- As far as peak fluctuations go, SELLAS Life Sciences Group's Consolidated Net Income rose by 13.14% in 2020, and later plummeted by 99.53% in 2022.
- Yearly analysis of 5 years shows SELLAS Life Sciences Group's Consolidated Net Income stood at -$19.3 million in 2019, then increased by 13.14% to -$16.8 million in 2020, then decreased by 23.52% to -$20.7 million in 2021, then slumped by 99.53% to -$41.3 million in 2022, then climbed by 8.31% to -$37.9 million in 2023.